Vinorelbine (VRB) plus gemcitabine (GEM) as first-line treatment for elderly patients (p) with advanced non-small cell lung cancer (NSCLC): Molecular correlates

被引：0
|
作者：
Maestu, I.
Isla, D.
Diz, P.
Munoz, J.
Oramas, J.
Garcia, R.
del Barco, S.
Provencio, M.
Taron, M.
Rosell, R.
机构：
[1] Hosp Virgen de los Lirios, Alcoy, Spain
[2] Hosp Clin Univ Lozano Blesa, Zaragoza, Spain
[3] Complejo Hosp Leon, Leon, Spain
[4] Hosp Univ Dr Peset, Valencia, Spain
[5] Hosp Univ Tenerife, San Cristobal la Laguna, Spain
[6] Hosp Univ Gregorio Maranon, Madrid, Spain
[7] Hosp Josep Trueta, Girona, Spain
[8] Hosp Puerta de Hierro, Madrid, Spain
[9] Hosp Badalona Germans Trias & Pujol, Badalona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18040
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Phase II trial of gemcitabine and cisplatin as first-line treatment of advanced non-small cell lung cancer (NSCLC).
    Lee, NS
    Byun, JH
    Bae, SB
    Kim, CK
    Lee, KT
    Park, SK
    Park, KK
    Won, JH
    Hong, DS
    Park, HS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 701S - 701S
  • [22] Combination of Gemcitabine (Gem) and Carboplatin (Carbo) as first line treatment in non-small cell lung cancer (NSCLC)
    Carrato, A
    Alberola, V
    Massuti, B
    Galan, A
    Sanchez, JJ
    Garcia-Gomez, J
    Diaz-Fernandez, N
    Meana, A
    Rodriguez-Lescure, A
    Gonzalvez, ML
    ANNALS OF ONCOLOGY, 1998, 9 : 89 - 90
  • [23] Docetaxel in combination with Gemcitabine as first-line treatment of patients with inoperable, locally advanced or metastatic non-small cell lung cancer (NSCLC)
    Barata, Fernando
    Sousa, Amelia
    Camacho, Elvira
    Costa, Marco S.
    Canario, Dolores
    Nogueira, Fernando
    Semedo, Eulalia
    ANNALS OF ONCOLOGY, 2004, 15 : 179 - 179
  • [24] BIWEEKLY CISPLATIN AND GEMCITABINE AS FIRST-LINE TREATMENT IN ADVANCED NON-SMALL CELL LUNG CANCER
    Benekli, Mustafa
    Gunaydin, Yusuf
    Inanc, Mevlude
    Ozkan, Metin
    Demirci, Ayse
    Demirci, Umut
    Suner, Ali
    Karaca, Halit
    Tonyali, Onder
    Berk, Veli
    Buyukberber, Suleyman
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S563 - S563
  • [25] First-line treatment of advanced non-small-cell lung cancer (NSCLC) with vinorelbine and cisplatin.
    Bobilev, D
    Ariad, S
    Geffen, DB
    Cohen, Y
    ANNALS OF ONCOLOGY, 2000, 11 : 118 - 118
  • [26] Phase II study of biweekly gemcitabine and docetaxel as first-line treatment for advanced disease in elderly non-small cell lung cancer (NSCLC) patients.
    Llorca, C.
    Esquerdo, G.
    Munoz, J., Sr.
    Sanchez-Hernandez, A.
    Gomez-Codina, J.
    Juan Vidal, O.
    Macia, S.
    Catot, S.
    Giner, V.
    Aparisi, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [27] Gemcitabine Plus Vinorelbine as the Second-Line Treatment and Beyond in Elderly Patients with Platinum-Pretreated Advanced Non-Small Cell Lung Cancer
    Go, Se-Il
    Lee, Won Sup
    Lee, Gyeong-Won
    Kang, Jung Hun
    Kang, Myoung Hee
    Song, Haa-Na
    Lee, Anna
    Lee, Un Seok
    Choi, Hye Jung
    Kim, Hoon-Gu
    CHEMOTHERAPY, 2014, 60 (04) : 267 - 273
  • [28] Platinum doublets as first-line treatment for elderly patients with advanced non-small cell lung cancer
    Piacentini, Paolo
    Greco, Filippo
    Mercanti, Anna
    Trolese, Anna Rita
    Durante, Emilia
    Moratello, Giacomo
    Tognetto, Michele
    Furini, Lara
    Giuliani, Jacopo
    Bonetti, Andrea
    TUMORI JOURNAL, 2013, 99 (06): : 650 - 655
  • [29] Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine
    De Pas, T
    de Braud, F
    Mandalà, M
    Curigliano, G
    Catania, C
    Ferretti, G
    Sozzi, P
    Solli, P
    Goldhirsch, A
    LUNG CANCER, 2001, 31 (2-3) : 267 - 270
  • [30] EFFICACY AND FEASIBILITY OF GEMCITABINE AND CARBOPLATIN AS FIRST-LINE CHEMOTHERAPY IN ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Lim, K.
    Lee, W.
    Kim, K.
    Lee, H.
    Han, S.
    Song, S.
    Kim, W. J.
    Lee, S.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S70 - S70
12345